SRTA Strata Critical Medical, Inc.
Industrials$6.14+0.16%ClosedMarket Cap: $531.3M
As of 2026-05-26
Valuation
P/E (TTM)
8.54
PEG
0.03
P/B
1.83
P/S
2.09
EV/EBITDA
-85.19
DCF Value
$-20.37
FCF Yield
-10.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
20.5%
Operating Margin
-6.0%
Net Margin
20.0%
ROE
19.0%
ROA
15.5%
ROIC
-4.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $67.4M | 18.7% | $-1.7M | $2.5M | $— | — |
| Q4 null | $66.8M | 15.3% | $-2.9M | $-5.4M | $— | — |
| FY null | $197.1M | 19.4% | $-9.8M | $-15.6M | $— | — |
| Q3 null | $49.3M | 23.6% | $-5.6M | $57.4M | $— | — |
| Q2 null | $70.8M | 25.1% | $-5.0M | $-3.7M | $— | — |
| Q1 null | $54.3M | 22.1% | $-7.6M | $-3.5M | $— | — |
| Q4 null | $54.4M | 23.2% | $-8.4M | $-9.8M | $— | — |
| FY null | $248.7M | 23.7% | $-33.9M | $-27.3M | $— | — |
| Q3 null | $74.9M | 26.5% | $-3.5M | $-2.0M | $— | — |
| Q2 null | $67.9M | 24.1% | $-12.1M | $-11.3M | $— | — |
| Q1 null | $51.5M | 19.7% | $-9.9M | $-4.2M | $— | — |
| Q4 2023 | $47.5M | 19.0% | $-35.6M | $-33.9M | $-0.45 | — |